UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential release of mast cell mediators and the pathogenesis of inflammation

Immunological reviews, 2007-06, Vol.217 (1), p.65-78

2007

Volltextzugriff (PDF)

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin

Proceedings of the National Academy of Sciences - PNAS, 2010-03, Vol.107 (9), p.4448-4453

2010

Volltextzugriff (PDF)

Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation

Clinical cancer research, 2011-01, Vol.17 (1), p.89-99

2011

Volltextzugriff (PDF)

Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4762-4768

2010

Volltextzugriff (PDF)

Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC

British journal of pharmacology, 2022-08, Vol.179 (15), p.3915-3933

2022

Volltextzugriff (PDF)

Mitochondrial Uncoupling Protein 2 Inhibits Mast Cell Activation and Reduces Histamine Content

The Journal of immunology (1950), 2009-11, Vol.183 (10), p.6313-6319

2009

Volltextzugriff (PDF)

Compartment-Specific Roles of ATP-Binding Cassette Transporters Define Differential Topotecan Distribution in Brain Parenchyma and Cerebrospinal Fluid

Cancer research (Chicago, Ill.), 2009-07, Vol.69 (14), p.5885-5892

2009

Volltextzugriff (PDF)

Review of delta-8-tetrahydrocannabinol (Δ 8 -THC): Comparative pharmacology with Δ 9 -THC

British journal of pharmacology, 2022-08, Vol.179 (15), p.3915-3933

2022

Volltextzugriff (PDF)

Pharmacokinetics of Two Nanoemulsion Formulations of Δ8-Tetrahydrocannabinol in Rats

AAPS PharmSciTech, 2023-11, Vol.24 (8), p.239-239, Article 239

2023

Volltextzugriff (PDF)

Simultaneous determination of cyclophosphamide and carboxyethylphosphoramide mustard in human plasma using online extraction and electrospray tandem mass spectrometry (HTLC–ESI-MS/MS)

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-06, Vol.877 (18), p.1709-1715

2009

Volltextzugriff (PDF)

Determination of the γ-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC–ESI-MS/MS)

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010-09, Vol.878 (25), p.2348-2352

2010

Volltextzugriff (PDF)

Pharmacokinetics of Two Nanoemulsion Formulations of Δ 8 -Tetrahydrocannabinol in Rats

AAPS PharmSciTech, 2023-11, Vol.24 (8), p.239

2023

Volltextzugriff (PDF)

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease

Journal of Psychopharmacology, 2023-09, Vol.37 (9), p.876-890

2023

Volltextzugriff (PDF)

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors

Dermatology and therapy, 2021-10, Vol.11 (5), p.1763-1776

2021

Volltextzugriff (PDF)

A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

Clinical cancer research, 2020-03, Vol.26 (6), p.1229-1236

2020

Volltextzugriff (PDF)

P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice

Drug metabolism letters, 2010-12, Vol.4 (4), p.195-201

2010

Volltextzugriff (PDF)

Recombinant prohormone convertase 1 and 2 cleave purified pro cholecystokinin (CCK) and a synthetic peptide containing CCK 8 Gly Arg Arg and the carboxyl-terminal flanking peptide

Peptides (New York, N.Y. : 1980), 2005-12, Vol.26 (12), p.2530-2535

2005

Volltextzugriff (PDF)

Tolerability of High-Dose Oral Δ 9 -THC: Implications for Human Laboratory Study Design

Cannabis and cannabinoid research, 2024-04, Vol.9 (2), p.437-448

2024

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

Clinical drug investigation, 2019-09, Vol.39 (9), p.873-887

2019

Volltextzugriff (PDF)

Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection

Biomedical chromatography, 2010-06, Vol.24 (6), p.626-631

2010

Volltextzugriff (PDF)

Abstract CT107: A Phase Ib study to evaluate the MEK inhibitor cobimetinib in combination with the ERK1/2 inhibitor GDC-0994 in patients with advanced solid tumors

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT107-CT107

2017

Volltextzugriff (PDF)

A phase I/II study of atezolizumab in pediatric and young adult patients with refractory/relapsed solid tumors (iMATRIX-Atezolizumab)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.10524-10524

2017

Volltextzugriff (PDF)

Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity

Cancer, 2012-11, Vol.118 (22), p.5663-5670

2012

Volltextzugriff (PDF)

Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

Clinical drug investigation, 2019-09, Vol.39 (9), p.889-890

2019

Volltextzugriff (PDF)

Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administration

Drug metabolism and disposition, 2011-01, Vol.39 (1), p.15-21

2011

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Englisch
(49)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(22)
Biological And Medical Sciences
(16)
Medical Sciences
(15)
Female
(12)
Male
(12)
Pharmacology. Drug Treatments
(11)
Pharmacology & Pharmacy
(10)
Animals
(9)
Oncology
(9)
Child
(7)
Mice
(7)
Adult
(6)
Child, Preschool
(6)
Tumors
(6)
Adolescent
(5)
Antineoplastic Agents - Pharmacokinetics
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Maximum Tolerated Dose
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential release of mast cell mediators and the pathogenesis of inflammation

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin

Role of ATP-Binding Cassette and Solute Carrier Transporters in Erlotinib CNS Penetration and Intracellular Accumulation

Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma

Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC

Mitochondrial Uncoupling Protein 2 Inhibits Mast Cell Activation and Reduces Histamine Content

Compartment-Specific Roles of ATP-Binding Cassette Transporters Define Differential Topotecan Distribution in Brain Parenchyma and Cerebrospinal Fluid

Review of delta-8-tetrahydrocannabinol (Δ 8 -THC): Comparative pharmacology with Δ 9 -THC

Pharmacokinetics of Two Nanoemulsion Formulations of Δ8-Tetrahydrocannabinol in Rats

Simultaneous determination of cyclophosphamide and carboxyethylphosphoramide mustard in human plasma using online extraction and electrospray tandem mass spectrometry (HTLC–ESI-MS/MS)

Determination of the γ-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC–ESI-MS/MS)

Pharmacokinetics of Two Nanoemulsion Formulations of Δ 8 -Tetrahydrocannabinol in Rats

The risk of chronic psychedelic and MDMA microdosing for valvular heart disease

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors

A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors

P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice

Recombinant prohormone convertase 1 and 2 cleave purified pro cholecystokinin (CCK) and a synthetic peptide containing CCK 8 Gly Arg Arg and the carboxyl-terminal flanking peptide

Tolerability of High-Dose Oral Δ 9 -THC: Implications for Human Laboratory Study Design

Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection

Abstract CT107: A Phase Ib study to evaluate the MEK inhibitor cobimetinib in combination with the ERK1/2 inhibitor GDC-0994 in patients with advanced solid tumors

A phase I/II study of atezolizumab in pediatric and young adult patients with refractory/relapsed solid tumors (iMATRIX-Atezolizumab)

Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity

Correction to: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers

Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administration

Suchergebnisse filtern